Oromandibular dystonia associated with SCA36

Mov Disord. 2013 Apr;28(4):558-9. doi: 10.1002/mds.25304. Epub 2013 Feb 6.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't
  • Video-Audio Media

MeSH terms

  • Botulinum Toxins, Type A / therapeutic use*
  • Dystonia / diagnosis
  • Dystonia / drug therapy*
  • Dystonic Disorders / diagnosis
  • Dystonic Disorders / drug therapy*
  • Dystonic Disorders / metabolism
  • Female
  • Humans
  • Middle Aged
  • Nerve Tissue Proteins / metabolism*
  • Nuclear Proteins / metabolism
  • Treatment Outcome

Substances

  • NOP56 protein, human
  • Nerve Tissue Proteins
  • Nuclear Proteins
  • Botulinum Toxins, Type A